Tuesday 19 Nov 2024
By
main news image

SINGAPORE (June 10): Healthcare provider AsiaMedic has appointed Choo Kin Poo as Chief Executive Officer from Friday.

Reporting to the board of directors, Choo will be responsible for carrying out the strategies and policies as established by the board and for the overall management, development and financial performance of the group.

Choo is currently the Group Vice-President for strategy planning, business development & operations at Luye Medicals Group, which is the controlling shareholder of AsiaMedic.

Luye is focused on developing global private healthcare services, hospitals, medical centres and network. Choo is also a non-executive board member of certain Luye companies in Australia and South Korea.

AsiaMedic says Choo has over 18 years of experience spanning strategy and planning, business development and mergers and acquisitions in the healthcare industry.

Prior to joining Luye, Choo held key positions at Covance Drug Development of Laboratory Corporation of America Holdings, the National Healthcare Group in Singapore and Hygieia Healthcare.

AsiaMedic shares closed 3.17% lower at 6 cents on Friday.

 

      Print
      Text Size
      Share